Olezarsen cuts triglycerides up to 60%, normalizing levels in 85% of high-risk patients.
CardiologyTRIALS < class="penci-entry-title entry-title grid-title penci_grid_title">Olezarsen cut triglycerides by 60%
Monthly Archives
September 2025
-
- CardiologyINTERNAL MEDICINETRIALS < class="penci-entry-title entry-title grid-title penci_grid_title">Baxdrostat delivers significant blood pressure reductions in patients with treatment-resistant hypertension.
Baxdrostat lowers BP in resistant hypertension, offering a new treatment option.